Recall of the intraocular lenses GBR/ Vivarte Myopic and Newlife/Vivarte Presbyopic from Ioltech
2007.04.03
Product group Non-active implants
Reference 00291/07
Ioltech S.A. (a company of Carl Zeiss Meditec AG) informs about a product recall and follow-up of implanted patients concerning the intraocular lenses GBR/ Vivarte Myopic and Newlife/Vivarte Presbyopic. Ciba Vision, who former marketed Vivarte intraocular lenses, also passes this information on their former Vivarte customers. According the manufacturer Ioltech S.A. studies show of a risk of endothelial cell loss increasing after two to three years of implantation.